Ako nekog zanima, ovo su informacije o adjuvanted cjepivu koje se daje kod nas. Cjepivo se zove Arepanrix i proizvodi ga GlaxoSmithKline u Kanadi. Ja nisam doktor, ne radim za nijednu farmaceutsku kompaniju (I wish

) i samo vam prenosim informacije koje su meni dostupne, a mozda nekom pomogne donjeti odluku koja je i meni bila teska za donjeti. Vase cjepivo moze biti drugacije od ovog koje se koristi u Kanadi. U svakom slucaju, uvijek se treba konzultirati sa lijecnikom.
How does the Arepanrix vaccine work?Arepanrix is an influenza vaccine made specifically to protect against the Pandemic H1N1 influenza strain. It is made exactly like the seasonal influenza vaccine that is produced each year, except for the addition of a "helper substance" called an "adjuvant". The "adjuvant" is a substance added to the vaccine to "help" the body make good protection (also called an immune response) against Pandemic H1N1 infection. This protection or immune response helps prevent the vaccinated person from getting sick if exposed to the Pandemic H1N1 virus. Using the helper adjuvant means a smaller amount of vaccine can be given with the each infection. Based on early studies, Arepanrix is expected to be very effective in preventing Pandemic H1N1 infection.
Arepanrix will not protect against seasonal influenza infection.
Who should get the Arepanrix and how many doses do they need?Pandemic H1N1 influenza vaccination is recommended for anyone six months of age and older who needs or wants protection against Pandemic H1N1 influenza infection. There is another Pandemic H1N1 influenza vaccine that is available for pregnant women that does not contain the adjuvant.
To ensure a good immune response, two doses at least 21 days apart are needed in the following groups:
- All children 6 months to less than 3 years of age:
- Children 3 years to less than 10 years of age with underlying medical problems.
Healthy children 3 years to less than 10 years of age, and anyone 10 years of age and older, only require one dose.
What are the risks from Arepanrix?Arepanrix is made exactly like the seasonal influenza vaccine that is produced each year, except for the addition of the helper "adjuvant". The seasonal influenza vaccine is very safe and serious side effects are very rare, and Arepanrix is expected to be just as safe. The adjuvant has been thoroughly studied in about 40,000 people and it has not been shown to cause any serious side effects. It should be noted that no pregnant women and few children less than 3 years of age were involved in the studies.
Because the influenza vaccine does not contain live virus, you cannot get flu from the vaccine. Minor side effects from Arepanrix are expected to include: pain and swelling where the injection is given, tiredness, muscle and joint pain, and headaches. Children may have a mild fever, be tired and irritable and not want to eat. As with the seasonal influenza vaccine, it is expected that most side effects will be mild, not last long and go away on their own.
Arepanrix is expected to be like the seasonal influenza vaccine where:
- Serious allergic reactions are very rare.
- An illness called Guillain-Barre Syndrome, which causes muscle paralysis, occurred after the influenza in 1976 and may occur very uncommonly after the seasonal influenza vaccine in some other influenza seasons.
- During the 2000-2001 influenza season, an "Oculo-Respiratory Syndrome" was reported after the seasonal influenza vaccine. ORS began within 24 hours after vaccination and was generally mild. Symptoms included red eyes, coughing, wheezing, and/or swelling of the face.
Who should not get Arepanrix? - Anyone who has had serious allergic reaction to:
-eggs or egg products
-a previous influenza vaccine
-thimerosal (a form of mercury found in other vaccines and contact lens solutions)
- Infants younger than 6 months of age
- People who are seriously ill with and infection that started recently should wait until they recover before getting Arepanrix.
- People who have had severe Oculo-Respiratory syndrome after a past influenza vaccine that required them to be in the hospital
- People with a history of Guillain-Barre Syndrome that developed within 8 weeks of a past influenza vaccine
People with bleeding disorders or who are taking medication that could affect blood clotting should discuss their medical situation with the nurse before receiving the vaccine.
Pregnant women can receive Arepanrix but the preferred product is the unadjuvanted Pandemic H1N1 influenza vaccine.